XML 53 R44.htm IDEA: XBRL DOCUMENT
v3.25.3

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Information |
Schedule of reportable segment information | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended September 30, | ​ | Nine months ended September 30, | ​
​ |  | 2025 |  | 2024 |  | 2025 |  | 2024 | ​
Revenue | ​ | $ | 7,491 | ​ | $ | 13,512 | ​ | $ | 24,543 | ​ | $ | 43,881 | ​
Less: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cost of revenue | ​ | ​ | 580 | ​ | ​ | 1,075 | ​ | ​ | 2,106 | ​ | ​ | 3,342 | ​
Research and development (1) | ​ | ​ | 1,106 | ​ | ​ | 1,165 | ​ | ​ | 3,642 | ​ | ​ | 3,695 | ​
Sales | ​ | ​ | 913 | ​ | ​ | 1,439 | ​ | ​ | 2,804 | ​ | ​ | 4,460 | ​
Sales operations | ​ | ​ | 754 | ​ | ​ | 697 | ​ | ​ | 2,281 | ​ | ​ | 2,260 | ​
General and administration | ​ | ​ | 7,993 | ​ | ​ | 3,128 | ​ | ​ | 17,989 | ​ | ​ | 8,902 | ​
Litigation settlement expense | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 29,750 | ​ | ​ | — | ​
Depreciation and amortization | ​ | ​ | 87 | ​ | ​ | 133 | ​ | ​ | 317 | ​ | ​ | 479 | ​
Other segment expenses (2) | ​ | ​ | 1,448 | ​ | ​ | 810 | ​ | ​ | 4,200 | ​ | ​ | 3,352 | ​
Segment operating (loss) profit | ​ | $ | (5,390) | ​ | $ | 5,065 | ​ | $ | (38,546) | ​ | $ | 17,391 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest income (expense), net | ​ | ​ | (338) | ​ | ​ | 168 | ​ | ​ | (214) | ​ | ​ | 1,699 | ​
Interest on 2030 Senior Notes | ​ | ​ | (1,237) | ​ | ​ | — | ​ | ​ | (3,312) | ​ | ​ | — | ​
Impairment of investments | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (1,135) | ​ | ​ | — | ​
Change in fair value of notes | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 128 | ​
Change in fair value of digital assets | ​ | ​ | 28,490 | ​ | ​ | 1,137 | ​ | ​ | 70,422 | ​ | ​ | (3,918) | ​
Change in fair value of Bitcoin collateral | ​ | ​ | 1,471 | ​ | ​ | — | ​ | ​ | 1,471 | ​ | ​ | — | ​
Gain on conversion of notes receivable | ​ | ​ | 803 | ​ | ​ | — | ​ | ​ | 803 | ​ | ​ | — | ​
Other corporate income (3) | ​ | ​ | 4 | ​ | ​ | 5 | ​ | ​ | 7 | ​ | ​ | 8 | ​
Income before taxes | ​ | ​ | 23,803 | ​ | ​ | 6,375 | ​ | ​ | 29,496 | ​ | ​ | 15,308 | ​
Income tax expense | ​ | ​ | 6,901 | ​ | ​ | 766 | ​ | ​ | 10,364 | ​ | ​ | 3,615 | ​
Net income | ​ | $ | 16,902 | ​ | $ | 5,609 | ​ | $ | 19,132 | ​ | $ | 11,693 | ​
​
| 1. | Research and development expenses include clinical affairs and HITRUST.
| 2. | Other segment expenses include marketing, customer education and business development.
| 3. | Other corporate income represents unallocated income.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration